India, March 18 -- Mankind Pharma Limited has acquired the Rivotril brand from Roche for the Indian market, securing exclusive rights to manufacture, market, and distribute the drug across the country.
Rivotril, a widely prescribed clonazepam-based medication for neurological and psychiatric conditions, is considered a well-established reference brand with a strong clinical legacy. The acquisition is expected to enhance Mankind Pharma's presence in the central nervous system (CNS) therapy segment and complement its existing neuro portfolio.
This move aligns with the company's increasing focus on chronic therapies, which now form a growing share of its overall business. Mankind has been expanding in this segment through new launches, in-li...